Concurrent TP53 mutations predict poor outcomes of EGFR-TKI treatments in Chinese patients with advanced NSCLC

Helei Hou,* Kang Qin,* Yu Liang, Chuantao Zhang, Dong Liu, Haiping Jiang, Kewei Liu, Jingjuan Zhu, Hongying Lv, Tianjun Li, Xiaochun ZhangDepartment of Medical Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, People’s Republic of China*These authors cont...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Hou H, Qin K, Liang Y, Zhang C, Liu D, Jiang H, Liu K, Zhu J, Lv H, Li T, Zhang X
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2019-06-01
Cyfres:Cancer Management and Research
Pynciau:
TP53
Epidermal growth factor receptor
Tyrosine kinase inhibitors
Non-small-cell lung cancer
Mutation
Exon
Mynediad Ar-lein:https://www.dovepress.com/concurrent-tp53-mutations-predict-poor-outcomes-of-egfr-tki-treatments-peer-reviewed-article-CMAR
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg